Administrative Core
Administrative Core
批准号:
7944986
负责人:
HARRIS A GELBARD
金额:
$14.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2010-07-31
关键词:
AIDS neuropathyAchievementAdherenceAdvisory CommitteesAttentionAwardBiometryBudgetsClinical TrialsDataDrug Delivery SystemsEnvironmentExpenditureFutureGenerationsGoalsGrantGuidelinesIn VitroIntellectual PropertyInterventionLaboratoriesLiteratureManuscriptsMolecular TargetNational Institute of Mental HealthNeuroprotective AgentsOccupational activity of managing financesPhase I Clinical TrialsPoliciesProgram ReviewsReportingResearch PersonnelResearch Project GrantsResourcesRestTestingTimeLineUnited States National Institutes of HealthUniversitiesWorkabstractingbasedata sharingin vivo Modelmeetingsmembermodel designnovelprograms
中文摘要
该计划项目组(PPG)声明的目标是确定药理学的分子靶标
在实验室模型中进行干预,为这些靶点设计合理的辅助神经保护药物
单独或联合使用,然后在体外和体内的神经艾滋病模型中进行测试,最终带来
这些策略中最成功的是在这笔赠款的授权期内进行第一阶段试验。核心A将
为该PPG提供全面的行政支持,并将协调所有项目和
核心。因此,该核心的职能是:(1)为每个项目/核心提供财政监督,并
总的PPG;(2)协调和精简这个PPG中出现的知识产权问题;(3)
及时向本PPG的所有调查人员提供数据信息/交换;(4)与CORE合作
D(生物统计学)根据NIH现行政策指导方针提供数据共享;(5)提供
为PPG调查员和我们的外部咨询人员之间的定期会议提供组织支持
委员会(选管会);以及最终,(6)精简我们的研究结果,并提供一个平台,以推动
最有希望的附加神经保护策略,用于考虑和纳入更高级的
未来的临床试验。核心A成员和PPG的其他成员之间的互动将提供最佳
为迅速完成我们的方案目标创造智力和行政环境。
英文摘要
The stated aims of this Program Project Group (PPG) are to define molecular targets for pharmacologic
intervention in laboratory models, design rational adjunctive neuroprotective drugs for these targets, either
singly or in combination, then test them in in vitro and in vivo models of neuroAIDS, and ultimately bring the
most successful of these strategies to Phase 1 trials within the award period of this grant. Core A will
provide overall administrative support for this PPG, and will also coordinate the activities of all Projects and
Cores. Thus, the functions of this Core are to: (1) provide fiscal oversight for each of the Projects/Cores and
the overall PPG; (2) coordinate and streamline the intellectual property issues that arise in this PPG; (3)
provide data information/exchange in a timely fashion to all investigators in this PPG; (4) in concert with Core
D (Biostatistics) provide data sharing in accordance with the current NIH policy guidelines; (5) provide
organizational support for regular meetings between the PPG investigators and our external advisory
committee (EAC); and ultimately, (6) streamline our findings and provide a platform for advancement of the
most promising adjunctive neuroprotective strategies for consideration and inclusion in more advanced
future clinical trials. Interactions between Core A members and the rest of the PPG will provide the optimal
intellectual and administrative environment for expeditious completion of our programmatic goals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunovascular interactions in postoperative delirium superimposed on dementia (DSD).
-
批准号:10524797
-
项目类别:
-
资助金额:$224.47万
-
财政年份:2022
-
负责人:HARRIS A GELBARD
-
依托单位:
Nanocrystal Quantum Dot Biomimetics of SARS-CoV-2 to Interrogate Neutrophil-Mediated Neuroinflammation at the Blood-Brain Barrier
-
批准号:10510611
-
项目类别:
-
资助金额:$42.35万
-
财政年份:2022
-
负责人:HARRIS A GELBARD
-
依托单位:
Immunoprofiling postoperative delirium during aging and neurodegeneration
-
批准号:10301230
-
项目类别:
-
资助金额:$23.98万
-
财政年份:2021
-
负责人:HARRIS A GELBARD
-
依托单位:
Immunoprofiling postoperative delirium during aging and neurodegeneration
-
批准号:10456947
-
项目类别:
-
资助金额:$19.85万
-
财政年份:2021
-
负责人:HARRIS A GELBARD
-
依托单位:
MLKi Therapy for Cognitive Impairment in Multiple Sclerosis
-
批准号:8904155
-
项目类别:
-
资助金额:$58.67万
-
财政年份:2015
-
负责人:HARRIS A GELBARD
-
依托单位:
Novel Kinase and Nanoformulated Protease Inhibitors for Eradication of CNS HIV-1
-
批准号:9302543
-
项目类别:
-
资助金额:$63.09万
-
财政年份:2014
-
负责人:HARRIS A GELBARD
-
依托单位:
Novel Kinase and Nanoformulated Protease Inhibitors for Eradication of CNS HIV-1
-
批准号:8893159
-
项目类别:
-
资助金额:$64.18万
-
财政年份:2014
-
负责人:HARRIS A GELBARD
-
依托单位:
Novel Kinase and Nanoformulated Protease Inhibitors for Eradication of CNS HIV-1
-
批准号:8736399
-
项目类别:
-
资助金额:$67.39万
-
财政年份:2014
-
负责人:HARRIS A GELBARD
-
依托单位:
Novel Kinase and Nanoformulated Protease Inhibitors for Eradication of CNS HIV-1
-
批准号:9107504
-
项目类别:
-
资助金额:$63.64万
-
财政年份:2014
-
负责人:HARRIS A GELBARD
-
依托单位:
Core--Cell and Molecular Core Facility
-
批准号:7891347
-
项目类别:
-
资助金额:$21.71万
-
财政年份:2009
-
负责人:HARRIS A GELBARD
-
依托单位:
Core--Biostatistics and Data Management
-
批准号:7891348
-
项目类别:
-
资助金额:$34.21万
-
财政年份:2009
-
负责人:HARRIS A GELBARD
-
依托单位:
Novel HIV Therapies
-
批准号:7891344
-
项目类别:
-
资助金额:$23.43万
-
财政年份:2009
-
负责人:HARRIS A GELBARD
-
依托单位:
Endogenous mechanisms of neuroprotection
-
批准号:7891343
-
项目类别:
-
资助金额:$21.07万
-
财政年份:2009
-
负责人:HARRIS A GELBARD
-
依托单位:
Core--Drug Design for the Molecular Target MLK-3
-
批准号:7891346
-
项目类别:
-
资助金额:$11.83万
-
财政年份:2009
-
负责人:HARRIS A GELBARD
-
依托单位:
Targeted Neuro Protection of HIV-1 Associated Neurologic Disease
-
批准号:7891345
-
项目类别:
-
资助金额:$45.84万
-
财政年份:2009
-
负责人:HARRIS A GELBARD
-
依托单位:
The Axon-Oligodendrocyte Precursor Synapse in NeuroAIDS
-
批准号:7495852
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2008
-
负责人:HARRIS A GELBARD
-
依托单位:
Core--Cell and Molecular Core Facility
-
批准号:7664370
-
项目类别:
-
资助金额:$29.29万
-
财政年份:2008
-
负责人:HARRIS A GELBARD
-
依托单位:
Targeted Neuro Protection of HIV-1 Associated Neurologic Disease
-
批准号:7664368
-
项目类别:
-
资助金额:$30.98万
-
财政年份:2008
-
负责人:HARRIS A GELBARD
-
依托单位:
Novel HIV Therapies
-
批准号:7664367
-
项目类别:
-
资助金额:$20.93万
-
财政年份:2008
-
负责人:HARRIS A GELBARD
-
依托单位:
Core--Drug Design for the Molecular Target MLK-3
-
批准号:7664369
-
项目类别:
-
资助金额:$10.49万
-
财政年份:2008
-
负责人:HARRIS A GELBARD
-
依托单位:
海外基金